Published date: 8 April 2021
Last edited date: 30 April 2021
This notice was replaced on 5 July 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 5 July 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Construction work - 45000000
Architectural, construction, engineering and inspection services - 71000000
Location of contract
North West
Value of contract
£100,000
Procurement reference
MEDDISC001-DN537041-02087572
Published date
8 April 2021
Closing date
30 April 2021
Closing time
12pm
Contract start date
9 May 2021
Contract end date
30 November 2021
Contract type
Works
Procedure type
Other: Open procedure
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. MEP: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=7ff6f212-7298-eb11-810c-005056b64545
About the buyer
Contact name
Kieran McGowan
Address
Block 35, Mereside
Alderley Park
Cheshire
SK10 4TG
England
Telephone
+44 1625708394
Kieran.McGowan@md.catapult.org.uk
Website
Share this notice